ENTO logo

Entero Therapeutics (ENTO) Interest Expense

ENTO Annual Interest Expense

$22.50 K
+$6600.00+41.51%

31 December 2023

ENTO Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENTO Quarterly Interest Expense

N/A

01 September 2024

ENTO Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENTO TTM Interest Expense

N/A

01 September 2024

ENTO TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENTO Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+41.5%--
3 y3 years-99.6%--
5 y5 years-77.9%--

ENTO Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+100.9%
5 y5-year-99.6%+100.9%
alltimeall time-99.6%+100.9%

Entero Therapeutics Interest Expense History

DateAnnualQuarterlyTTM
Mar 2024
-
$66.20 K(+1224.0%)
$71.20 K(+237.4%)
Dec 2023
$22.50 K(+41.5%)
-
-
June 2023
-
$5000.00(-44.4%)
$21.10 K(+9.3%)
Mar 2023
-
$9000.00(+45.2%)
$19.30 K(+21.4%)
Dec 2022
$15.90 K(+42.0%)
-
-
Dec 2022
-
$6200.00(+588.9%)
$15.90 K(+31.4%)
Sept 2022
-
$900.00(-71.9%)
$12.10 K(+1.7%)
June 2022
-
$3200.00(-42.9%)
$11.90 K(+1.7%)
Mar 2022
-
$5600.00(+133.3%)
$11.70 K(+4.5%)
Dec 2021
$11.20 K(-99.8%)
$2400.00(+242.9%)
$11.20 K(+1.8%)
Sept 2021
-
$700.00(-76.7%)
$11.00 K(-99.1%)
June 2021
-
$3000.00(-41.2%)
$1.21 M(-65.5%)
Mar 2021
-
$5100.00(+131.8%)
$3.51 M(-39.9%)
Dec 2020
$5.84 M(+1246.1%)
$2200.00(-99.8%)
$5.84 M(-2.6%)
Sept 2020
-
$1.20 M(-47.7%)
$5.99 M(+22.3%)
June 2020
-
$2.30 M(-1.3%)
$4.90 M(+80.9%)
Mar 2020
-
$2.33 M(+1397.3%)
$2.71 M(+524.5%)
Dec 2019
$433.90 K
$155.80 K(+41.1%)
$433.90 K(+55.2%)
DateAnnualQuarterlyTTM
Sept 2019
-
$110.40 K(-0.2%)
$279.50 K(+60.0%)
June 2019
-
$110.60 K(+93.7%)
$174.70 K(+58.4%)
Mar 2019
-
$57.10 K(+3978.6%)
$110.30 K(+8.3%)
Dec 2018
$101.80 K(-88.4%)
$1400.00(-75.0%)
$101.80 K(-63.6%)
Sept 2018
-
$5600.00(-87.9%)
$279.30 K(-59.0%)
June 2018
-
$46.20 K(-4.9%)
$681.80 K(-26.1%)
Mar 2018
-
$48.60 K(-72.8%)
$922.90 K(+5.5%)
Dec 2017
$875.20 K(-85.3%)
$178.90 K(-56.2%)
$875.20 K(-81.8%)
Sept 2017
-
$408.10 K(+42.0%)
$4.81 M(-6.2%)
June 2017
-
$287.30 K(>+9900.0%)
$5.12 M(-1.9%)
Mar 2017
-
$900.00(-100.0%)
$5.22 M(-12.0%)
Dec 2016
$5.94 M(+274.0%)
$4.11 M(+467.1%)
$5.94 M(+140.2%)
Sept 2016
-
$724.90 K(+86.8%)
$2.47 M(+9.0%)
June 2016
-
$388.10 K(-45.6%)
$2.27 M(+5.1%)
Mar 2016
-
$713.70 K(+10.7%)
$2.16 M(+35.8%)
Dec 2015
$1.59 M
$644.90 K(+23.9%)
$1.59 M(+68.4%)
Sept 2015
-
$520.60 K(+87.7%)
$942.70 K(+123.3%)
June 2015
-
$277.40 K(+91.7%)
$422.10 K(+191.7%)
Mar 2015
-
$144.70 K
$144.70 K

FAQ

  • What is Entero Therapeutics annual interest expense?
  • What is the all time high annual interest expense for Entero Therapeutics?
  • What is Entero Therapeutics annual interest expense year-on-year change?
  • What is the all time high quarterly interest expense for Entero Therapeutics?
  • What is the all time high TTM interest expense for Entero Therapeutics?

What is Entero Therapeutics annual interest expense?

The current annual interest expense of ENTO is $22.50 K

What is the all time high annual interest expense for Entero Therapeutics?

Entero Therapeutics all-time high annual interest expense is $5.94 M

What is Entero Therapeutics annual interest expense year-on-year change?

Over the past year, ENTO annual interest expense has changed by +$6600.00 (+41.51%)

What is the all time high quarterly interest expense for Entero Therapeutics?

Entero Therapeutics all-time high quarterly interest expense is $4.11 M

What is the all time high TTM interest expense for Entero Therapeutics?

Entero Therapeutics all-time high TTM interest expense is $5.99 M